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Abstract
Background: Circular forms of viral genomic DNA are generated during infection of cells with
retroviruses like HIV-1. Such circles are unable to replicate and are eventually lost as a result of
cell division, lending support to the prevalent notion that episomal retroviral DNA forms are dead-
end products of reverse transcription.
Results: We demonstrate that circular DNA generated during transduction with HIV-1-based
lentiviral vectors can be utilized as substrate for gene insertion directed by nonviral recombinases
co-expressed in the target cells. By packaging of lentiviral genomic RNA in integrase-defective
lentiviral vectors, harboring an inactive form of the viral integrase, the normal pathway for viral
integration is blocked and circular vector DNA accumulates in transduced cells as a result. We find
that the amount of DNA circles is increased 4-fold in cells transduced with integration-defective
vectors relative to cells treated with integrase-proficient vectors. By transduction of target cells
harboring engineered recognition sites for the yeast Flp recombinase with integration-defective
lentiviral vectors containing an ATG-deficient hygromycin B selection gene we demonstrate precise
integration of lentiviral vector-derived DNA circles in a drug-selective approach. Moreover, it is
demonstrated that trans-acting Flp recombinase can be delivered by Flp-encoding transfected
plasmid DNA or, alternatively, by co-transduced integrase-defective lentiviral vectors carrying a Flp
expression cassette.
Conclusion: Our data provide proof-of-principle that nonviral recombinases, like Flp, produced
by plasmid DNA or non-integrating lentiviral vectors can gain access to circular viral recombination
substrates and facilitate site-directed genomic insertion of such episomal DNA forms. Replacement
of the normal viral integration machinery with nonviral mediators of integration represents a new
platform for creation of lentiviral vectors with an altered integration profile.
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Integration of foreign DNA plays a pivotal role in genetic
engineering, animal transgenesis, and therapeutic gene
transfer. Lentiviral vectors (LV) efficiently insert genetic
cargo in both dividing and non-dividing cells and have
attracted, therefore, major attention as a gene transfer
tool. During lentiviral transduction, linear vector DNA is
associated with viral and cellular proteins in the preinte-
gration complex (PIC) which is transported across the
nuclear membrane and facilitates tethering of viral
genomic DNA to chromatin. As part of the PIC, cellular
LEDGF/p75 is thought to anchor viral DNA on chroma-
tin, allowing the viral integrase to insert viral DNA in a
fashion that supposedly favors integration in actively tran-
scribed genes [1-3]. Great interest is attracted to ways of
altering the lentiviral integration profile, allowing gene
insertion in predetermined and safe vector landing sites. It
remains unknown, however, whether lentiviral integra-
tion can be directed by alternative integration machiner-
ies, despite the integrity of the PIC and the exquisite
involvement of cellular factors in nuclear entry and chro-
matin association.
During lentivirus infection circular forms of the viral
genomic DNA are generated by either non-homologous
end joining (NHEJ) of the full-length linear viral DNA
(creating 2-LTR circles) [4], or by homologous recombina-
tion between the two LTRs of the episomal viral DNA (cre-
ating 1-LTR circles) [5]. Such episomal DNA circles have
traditionally been considered dead-end products of
reverse transcription [5] and are eventually lost together
with episomal linear vector forms as a result of host cell
division. However, integration-defective lentiviral (IDLV)
vectors carrying an inactive integrase protein that abolish
the normal viral integration pathway have recently
emerged as novel efficient gene carriers, facilitating high
levels of transient expression from linear and circular
DNA forms [6-9]. Increased persistence of transgene
expression in dividing cells has been demonstrated by
allowing circles harboring the simian virus 40 (SV40) ori-
gin of replication to replicate episomally in cells contain-
ing the SV40 large T antigen [9]. Moreover, non-
integrating lentiviral vectors have been shown to facilitate
stable in vivo therapeutic levels of transgene expression in
non-dividing neuronal cells [8] and muscle [6]. Recently,
the episomal nature of the integration-defective vectors
was further exploited as a template source for high-effi-
cient gene correction by homologous recombination in
human cell lines and in human embryonic stem cells
[10,11].
High stability and accessibility of DNA circles by cellular
proteins have led us to suggest that stable circular DNA
intermediates can be engineered to act as putative sub-
strates for gene insertion by nonviral gene-inserting pro-
teins. We test this hypothesis here by using a model
system based on the actions of the site-directed Flp recom-
binase and demonstrate for the first time that LV-derived
DNA circles can serve as a substrate for gene insertion
facilitated by exogenous nonviral recombinases. Our find-
ings provide evidence that trans-acting integrases are able
to gain access to and insert transduced lentiviral DNA with
possible application in (i) viral vector manipulation for
improved viral gene transfer and (ii) Flp-based cell engi-
neering methods focusing on hard-to-transfect cells and/
or creation of site-directed gene insertions that do not
contain bacterial remnants of plasmid DNA.
Methods
Vector construction
The HIV-1-derived Flp substrate vector, pLV/FRT-hygro,
was generated by replacing the eGFP gene (BamHI/XhoI
digestion) of the third generation SIN-vector
pCCL.WPS.PGK-eGFP.WHV (a kind gift from Dr. Patrick
Aebischer, Swiss Federal Institute of Technology, EPFL,
Lausanne, Switzerland) with the puromycin resistance
gene, PCR-amplified from pT/PGK-Puro [12] (creating
pCCL.WPS.PGK-Puro.WHV), followed by insertion of the
ATG-deficient FRT-hygro fusion gene (PCR-amplified
from pcDNA5/FRT, Invitrogen) into the HpaI site located
upstream of the cPPT The SB-based docking vector, pSBT/
RSV-FGIP, was generated by amplifying the eGFP
sequence (from peGFP.N1, Clontech) using a forward
primer containing the 48-bp FRT sequence and inserting
the resulting FRT.GFP fusion gene into MluI/XmaI-
digested pSBT/RSV-hAAT [12] (generating pSBT/RSV-
FRT.GFP) prior to insertion of an IRES-puro cassette
(PCR-amplified from pecoenv-IRES-puro, kindly pro-
vided by Dr. Finn Skou Pedersen, University of Aarhus,
Denmark), into the XmaI site. pLV/PGK-Flp was gener-
ated by replacing the eGFP gene of pCCL.WPS.PGK-
eGFP.WHV with the Flpx9 gene [13] PCR-amplified from
pCMV-Flp (obtained from A. Francis Stewart, University
of California San Francisco, USA), the latter which con-
tains the enhanced x9 Flp variant driven by a cytomegalo-
virus (CMV) promoter. pCMV-SB contains the SB10
transposase gene driven by a CMV promoter and has been
described previously [14].
Lentiviral vector production
HEK-293 and 293T cells were cultured at 37°C in 5% (v/
v) CO2 and maintained in Dulbecco's modified Eagle's
medium (Cambrex, Verviers, Belgium) with D-glucose
(4.500 mg/liter) supplemented with 10% fetal calf serum,
penicillin (100 U/ml), streptomycin (0.1 mg/ml), and L-
glutamine (265 mg/liter). When selection was applied,
puromycin (Sigma, St. Louis, MO) or hygromycin B (Inv-
itrogen, Carlsbad, CA) was added to the growth medium
to a final concentration of 1 μg/ml or 200 μg/ml, respec-
tively.Page 2 of 10
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CaPO4-transfection of 293T cells (seeded at 3 × 106 cells/
dish in 10-cm dishes) with 3 μg pRSV-Rev, 3.75 μg
pMD.2G (VSV-G), 13 μg pMDLg/pRRE (or 13 μg pMDLg/
pRREintD64V [8] for production of integration-defective
vectors) and 13 μg lentiviral vector plasmid. The superna-
tant was harvested two days post-transfection and poly-
brene was added to a final concentration of 8 μg/ml prior
to transfer to target cells.
Generation and transfection of FRT-tagged cell lines
FRT-tagged HEK-293-derived cell lines were generated by
transfecting HEK-293 cells (seeded at 2 × 105 cells/well in
6 well plates) with 1.5 μg pSBT/RSV-FGIP and 0.5 μg
pCMV-SB [14] (using 4 μl Fugene-6; Roche, Basel, Swit-
zerland) and selecting for puromycin resistance. Resistant
clones were isolated and expanded. For evaluating the
efficacy of Flp-mediated insertion of transgenes into the
engineered FRT docking site, FRT-tagged cell lines (seeded
at 7 × 105 cells/dish in 10-cm dishes, n = 3) were CaPO4-
transfected with 2 μg pLV/FRT-hygro and 10 μg pCMV-Flp
or 10 μg pUC19 (negative control). Two days after trans-
fection the cell lines were split, diluted, and selected for 10
days with hygromycin B prior to counting of hygromycin
B-resistant colonies.
Quantification of viral DNA forms in transduced cells
HEK/FGIP1 cells (seeded at 3 × 106 cells/dish in 10-cm
dishes, n = 3) were transduced with LV/FRT-hygro or
IDLV/FRT-hygro (~4.33 × 106 and ~3.79 × 106 pg p24,
respectively). Hirt DNA was harvested 24 hours post-
transduction. The amount of total HIV DNA and 2-LTR
circles was quantified by real time PCR performed on an
iCycler Thermal Cycler (Bio-Rad) using the DyNAmo HS
SYBR Green qPCR Kit (Finnzymes, Espoo, Finland). Total
HIV DNA was quantified by amplifying a part of the
Woodchuck Hepatitis Virus (WHV) posttranscriptional
regulatory element present in the vector backbone, and 2-
LTR circles were amplified by using primers spanning the
LTR-LTR junction. Copy numbers of total HIV DNA and
2-LTR circles were determined from standard curves cre-
ated by PCR amplification on matching control DNA tem-
plates. Concentrations of p24 Gag were measured using a
HIV-1 p24 ELISA kit (ZeptoMetrix, Buffalo, NY). To rule
out possible overestimation of the total vector DNA due
to putative contamination with plasmid DNA, we carried
out a quantitative PCR analysis using a primer set ampli-
fying an amplicon within the Amp resistance gene in the
plasmid backbone. A pLV/FRT-hygro plasmid dilution
series was used as qPCR standard to verify sufficient sensi-
tivity of the assay to detect plasmid contamination. Con-
taminating plasmid DNA was detected within the range of
the assay but was neglectable relative to levels of total vec-
tor DNA in transduced cells.
Flp-directed insertion of lentiviral DNA circles
HEK/FGIP1 (n = 3) and HEK/FGIP2-6 (n = 1) cell lines
were seeded at a total of 7 × 105 cells/dish in 10-cm dishes.
For combined transfection-transduction assays the trans-
fections were performed by CaPO4 using a total of 10 μg
pCMV-Flp or 2 μg pLV/FRT-hygro, respectively. Transduc-
tions were performed using IDLV/FRT-hygro (~4.8 × 105
pg p24) or IDLV/PGK-Flp (~17 × 105 pg p24) vectors. The
cells were grown in non-selective medium for two days
before being subjected to hygromycin B selection. In co-
transduction assays the cells were infected with IDLV/FRT-
hygro (~4.8 × 105 pg p24) and IDLV/PGK-Flp (~17 × 105
pg p24) before being subjected to hygromycin B selection.
All experiments were performed using an empty Flp-defi-
cient vector as a negative control.
Analyses of clones carrying inserted DNA circles
Southern blot analysis was performed using 10 μg XbaI-
digested genomic DNA isolated from hygromycin B-resist-
ant clones. The digested DNA was separated on a 0.8%
agarose gel, transferred to a nitrocellulose membrane,
hybridized to a 700-bp 32P-labeled probe, derived from
the hygromycin B resistance gene, and subjected to auto-
radiography. HEK-293 genomic DNA spiked with pLV/
FRT-hygro and digested with XbaI (which cuts at a single
site in pLV/FRT-hygro) was utilized as a positive control.
PCR-based analyses of Flp-directed circle insertions were
performed using genomic DNA from isolated hygromycin
B-resistant clones. Primer sequences are available upon
request.
Results and Discussion
To provide proof-of-principle that trans-acting nonviral
recombinases are able to gain access to lentivirally deliv-
ered substrates and facilitate their insertion, we designed
an LV-derived hybrid integration system based upon the
integrating properties of the yeast Flp recombinase. First,
we constructed an LV substrate vector, pLV/FRT-hygro,
containing an ATG-deficient FRT-hygro fusion cassette in
the context of a self-inactivating (SIN) LV vector (Figure
1A). The Flp recombination target (FRT) sequence is rec-
ognized by the Flp recombinase which mediates recombi-
nation between two identical FRT sites. By including the
FRT sequence in this vector, we reasoned that LV DNA cir-
cles generated during vector transduction would serve as
substrates for Flp-dependent site-directed insertion of
viral DNA into FRT sites engineered into the genome of
transduced cells. Integration of the ATG-deficient FRT-
hygro fusion gene into an engineered FRT site flanked
upstream by a promoter and an ATG sequence would
regenerate a functional hygromycin B expression cassette,
allowing selection of cells containing site-directed vector
insertion (Figure 1B). Hence, by using a site-directed Flp-
based approach, we were able to score circle insertions
selectively but also suspected a low circle insertion ratePage 3 of 10
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Figure 1
Strategy for Flp-directed integration of lentiviral DNA circles. (A) Schematic representation of vectors utilized for lentiviral 
transduction and generation of Sleeping Beauty vector-tagged cell lines. The lentiviral vector, pLV/FRT-hygro, is a third genera-
tion SIN vector containing an ATG-deficient FRT-hygro fusion gene located between the packaging signal (ψ) and the central 
polypurine tract (cPPT, not shown) flanked downstream by a selectable marker expression cassette. In the lentiviral SIN vector 
pLV/PGK-puro the PGK-driven Flpx9 expression cassette is located downstream from ψ and cPPT sequence (the latter not 
shown). The SB transposon docking vector, pSBT/RSV-FGIP, contains the left and inverted repeats of SB (LIR and RIR, repre-
sented by white arrows) and an expression cassette containing the RSV promoter driving a fusion gene consisting of an ATG-
FRT-tagged eGFP gene, an IRES element, the puromycin-resistance gene, and a polyadenylation signal. (B) Schematic represen-
tation of site-directed integration of LV DNA circles. After reverse transcription of the viral RNA, circular forms of the viral 
genomic DNA are generated by either non-homologous end joining (2-LTR) or homologous recombination (1-LTR). These cir-
cles are normally considered dead-end products of reverse transcription but the FRT site will enable DNA circles to become 
substrates for Flp recombination. In cells harboring an engineered FRT site flanked by a promoter and a start codon, Flp-medi-
ated insertion of the virus-derived (i) 1-LTR circles and (ii) 2-LTR circles will generate a functional hygromycin B resistance 
expression cassette. To block the normal viral integration machinery, integration-defective lentiviral vectors (IDLVs), carrying 
an inactive viral integrase protein (harboring the D64A mutation), were utilized as carriers of viral RNA. Puro, puromycin 
resistance gene; LTR, long terminal repeat; FRT, Flp recombination target site.
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transduced cells.
The conditions for the Flp-based integration machinery
were optimized by packaging vector RNA in virus particles
carrying an inactive viral integrase protein harboring the
class I D64V mutation [15]. By blocking the normal viral
integration machinery, we were able to increase the copy
number of 2-LTR circles from 3.8 to 22 circles per cell (Fig-
ure 2) corresponding to a 3.9-fold increase of circular
DNA (correlated to the total amount of HIV-1 DNA) avail-
able for Flp-based recombination in transduced cells (Fig-
ure 2). To rule out possible overestimation of the total
vector DNA due to plasmid contamination, we carried out
a quantitative PCR analysis using a plasmid-specific
primer set amplifying an amplicon within the Amp resist-
ance gene in the plasmid backbone. Although within the
detection limit of the assay, the level of contaminating
plasmids was neglectable relative to measured copy num-
bers of total vector DNA (data not shown) and consid-
ered, therefore, to be without notable influence on
measurements of total vector DNA. Importantly, the inte-
grase mutation did not influence production or transduc-
tion capacity of the viral particles, since p24 values of the
virus preparations and the total amount of episomal vec-
tor DNA present in the transduced cells were comparable
between vector preparations carrying active and inactive
viral integrase (Figure 2). In accordance with previous
reports [6,16] the titer of integrase-deficient vectors was
reduced approximately 1000-fold (from ~108 to ~105
CFU/ml) compared to vectors carrying the active integrase
(data not shown).
To tag chromosomal DNA with recognition sequences for
the Flp recombinase, we generated a Sleeping Beauty [14]
(SB) transposon-derived docking vector, pSBT/RSV-FGIP,
containing the Flp recombination target (FRT) sequence
as part of a new active fusion variant of the eGFP reporter
gene (Figure 1A). The eGFP fusion gene, containing an
FRT sequence between the start codon and the remaining
part of the eGFP coding sequence, was flanked down-
stream by an IRES element and the puromycin resistance
gene. The docking SB transposon was inserted into the
genomic DNA of HEK-293 cells by co-transfection of
pSBT/RSV-FGIP with pCMV-SB, a plasmid encoding the
SB transposase. To provide optimal conditions for subse-
quent Flp-based gene insertion, we utilized conditions
which in our hands consistently allow insertion of >1 vec-
tor in transfected HEK-293 cells. The rationale was to cre-
ate a cell line tagged with at least two docking sites.
Among several eGFP-positive HEK-293 cell lines that were
generated by puromycin selection, one cell line, HEK/
FGIP1, was utilized for further studies. This particular cell
line was found to contain at least 3 vector insertions, as
determined by Southern blot analysis (data not shown).
To confirm functionality of the FRT sequence in the con-
text of the eGFP fusion gene, HEK/FGIP1 cells were co-
transfected with 2 μg plasmid carrying an ATG-deficient
FRT-hygro cassette (pLV/FRT-hygro) and 10 μg plasmid
encoding Flp recombinase. Subsequent hygromycin B
selection demonstrated efficient insertion into the engi-
neered FRT site (Figure 3A). Analysis of the transfected
HEK-SB/FGIP1 cells by quantitative PCR (data not
shown) showed that each cell on average contained 1.3 ×
104 ± 2.3 × 103 FRT-tagged donor plasmids 24 hours after
transfection, leading to an estimated insertion rate of 2.8
× 10-7 Flp-based insertions per single copy of transfected
FRT-hygro-containing plasmid in the culture. Notably, co-
transfection of FRT-hygro substrate plasmid with a nega-
tive control plasmid did not result in colony formation,
demonstrating the absolute lack of false positives in the
system. As expected by the presence of >1 docking inser-
tion in this cell line, eGFP expression was not turned off
in hygromycin B resistant cells due to the fact that not all
docking sites had been targeted by Flp recombination.
However, subsequent PCR and sequence analysis of mul-
tiple hygromycin B-resistant clones confirmed correct Flp-
based plasmid insertion in the eGFP gene of the integrated
docking vector (data not shown). In summary, these data
provide evidence that the Flp docking construction con-
taining the novel FRT-eGFP fusion gene is functional in
context of an integrated SB vector.
During lentiviral transduction double-stranded viral DNA
is transported through the nuclear membrane as part of
the PIC consisting of both viral and cellular proteins.
Attempts to access the viral DNA by nonviral recombi-
nases may therefore be hampered by the reduced DNA
accessibility within the context of the PIC. To demonstrate
that Flp indeed can gain access to the circular viral DNA
and facilitate genomic insertion of LV circular substrates,
we transfected the HEK/FGIP1 cell line with a Flp expres-
sion plasmid one day prior to transduction with the inte-
gration-defective (ID) LV/FRT-hygro vector (see Figure
1A). After hygromycin B selection 97 ± 15 resistant colo-
nies were obtained (Figure 3B), whereas resistant colonies
could not be detected in cells transfected with an empty
control plasmid prior to IDLV/FRT-hygro transduction.
To examine whether IDLVs, co-transduced with DNA cir-
cle donor IDLVs, could serve as a source of Flp recombi-
nase we created an LV SIN vector, pLV/PGK-Flpx9,
containing a PGK-driven Flp gene (Figure 1A). First, HEK/
FGIP1 cells were transduced with IDLV/PGK-Flp and on
the following day transfected with an FRT-tagged plasmid
substrate (pLV/FRT-hygro). After two weeks of hygromy-
cin B selection, we detected 35 ± 9 drug-resistant colonies
as a result of Flp-mediated plasmid insertion (Figure 3C),
whereas transduction with a viral vector, IDLV/PGK-eGFP,
lacking the Flp expression cassette did not result in anyPage 5 of 10
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recombinase, transiently expressed from integration-
defective LV vectors, was able to confer substrate recombi-
nation and site-specific gene insertion. We finally co-
transduced the HEK/FGIP1 cell line with IDLV/FRT-hygro
and IDLV/PGK-Flp and subsequently selected transduced
cells for hygromycin B resistance. In this setup, we
obtained 58 ± 6 colonies per co-transduction (Figure 3D).
To examine whether the efficiency of Flp-directed gene
insertion varied among clones tagged with the docking
vector, we generated five additional FRT-tagged HEK
clones (HEK/FGIP2-6). All these cell lines demonstrated
levels of eGFP expression that were comparable with the
expression of eGFP in HEK/FGIP1 as measured by FACS
analysis (data not shown). By co-transduction of these cell
lines with IDLV/FRT-hygro and IDLV/PGK-Flp we
obtained from 15 to 35 hygromycin B-resistant colonies
(Figure 3E), indicating that efficiency of LV circle insertion
varied only to a small degree between the tested FRT-
tagged clones.
To demonstrate that the DNA circles were precisely
inserted by Flp into the FRT docking site, we first analyzed
five representative clones by southern blot analysis of
genomic DNA digested with XbaI, which cuts within the
duplicated FRT sequences (Figure 4A). This analysis veri-
fied that full-length circles had been site-specifically
inserted. To further characterize the inserted DNA circles
22 clones (10 and 12 clones from figure 3B and 3D,
respectively) were isolated and analyzed. PCR amplifica-
tion of genomic DNA using primer sets flanking the
upstream and downstream FRT junction sites, respec-
tively, resulted in PCR fragments indicative of site-specific
circle insertion into the SB-tagged locus (Figure 4B, panel
I–II and V–VI). Sequencing of these PCR products con-
firmed precise recombination between the genomic FRT
site and the circle-associated FRT site, except for one clone
(clone 14) in which part of the downstream region of the
vector had been deleted. Although this clone carried
marks of an inaccurate circle insertion, it could alterna-
tively be the result of Flp-based recombination between a
linear substrate and the genomic FRT site. In theory, linear
substrates may be as efficient substrates as their circular
counterparts but the outcome of vector incorporation into
the genomic FRT site may differ. Whereas circular forms
are resolved by the Flp recombinase into the genomic site
without generating DNA breaks, linear forms containing
free LTR ends would be expected to generate potentially
harmful double-strand DNA breaks. Such complications
would suggest that LV hybrid systems based upon cut-
and-paste transposases acting on circular and linear sub-
strates may be advantageous and perhaps safer than
recombinase-based systems.
Next, we carried out PCR amplification and sequencing of
fragments containing the LTRs of the site-directed inser-
tions. Eight 1-LTR and fourteen 2-LTR circle integrations,
created by Flp-based insertion of circles generated by
homologous recombination and NHEJ, respectively, were
detected (Figure 4B, panel III and VII) confirming that
the integrated DNA in each clone was indeed derived from
circular substrates. We analyzed 33 additional clones and
from a total of 55 clones, 30 1-LTR and 25 2-LTR inser-
tions were identified (data not shown). According to pre-
vious findings claiming a 9:1 ratio of 1-LTR to 2-LTR
circles present in transduced cells [17], there appears to be
a preference for insertion of 2-LTR circles in our system.
Although this finding could reflect differences in the cel-
lular location of circle species and/or their accessibility for
proteins in trans, possible explanations remain specula-
tive. Altogether, our data demonstrate that DNA circles
generated during lentiviral transduction are indeed acces-
Blockage of the normal viral integration machinery increases the formation of LV DNA circles in transduced cellsFigure 2
Blockage of the normal viral integration machinery increases 
the formation of LV DNA circles in transduced cells. HEK-
SB/FGIP cells were infected with integration-proficient or 
integration-deficient lentiviral vectors. Hirt DNA was har-
vested 24 hours post-transduction and subsequently used for 
Q-PCR analysis to determine the amount of linear and circu-
lar lentiviral DNA. Transductions were performed in tripli-
cates and presented as mean value + SD.Page 6 of 10
(page number not for citation purposes)
BMC Biotechnology 2008, 8:60 http://www.biomedcentral.com/1472-6750/8/60
Page 7 of 10
(page number not for citation purposes)
Figure 3
Episomal lentiviral DNA can act both as a substrate for Flp recombination and as a source of Flp recombinase for site-directed 
genomic integration. (A) Flp-mediated integration of plasmids into FRT-tagged HEK-derived cell line. The HEK/FGIP1 cell line 
was transfected with pLV/FRT-hygro and pCMV-Flp or a negative control and selected for hygromycin B resistance. (B) Flp-
mediated integration of lentiviral DNA circles. HEK/FGIP1 cells were transfected with pCMV-Flp or a negative control one day 
prior to transduction with the IDLV/FRT-hygro vector. (C) Transient expression of Flp recombinase from integration-defec-
tive LV vectors is sufficient for site-directed insertion of donor plasmid. HEK/FGIP1 cells were transduced with IDLV/PGK-Flp 
or a negative control and on the following day transfected with pLV/FRT-hygro. (D-E) IDLV-encoded Flp catalyzes site-
directed genomic integration of lentiviral DNA circles. HEK/FGIP1-6 cells were co-transduced with IDLV/FRT-hygro and IDLV/
PGK-Flp or a negative control. Transfections/transductions were performed in triplicates (except for in panel E in which n = 1) 
and presented as mean value + SD.
BMC Biotechnology 2008, 8:60 http://www.biomedcentral.com/1472-6750/8/60sible for nonviral integrases in trans and may serve as sub-
strates for genomic recombination by Flp protein
transiently delivered by an integration-defective vector.
Based upon 2-LTR copy numbers, measured by q-PCR, we
calculated an estimated insertion rate of 1.7 × 10-5 Flp-
based insertions per single copy of transduced 2-LTR circle
(number of drug-resistant colonies containing a 2-LTR
insertion/(number of 2-LTR circles per cell × total number
of transduced cells)), leading us to suggest that 2-LTR cir-
cles, in comparison to transfected plasmid DNA, might be
more efficient substrates for Flp-based recombination.
The D64V mutation in the HIV-1 integrase protein
removes all enzymatic activity of the protein and has been
reported to reduce integration of vector DNA 1.000–
10.000-fold [6,15,16]. We reproducibly measured a 1000-
fold reduction by colony-forming assays and, hence,
could not formally rule out that integrase-independent
insertion of linear IDLV/FRT-hygro or IDLV/PGK-Flp
could have occurred in hygromycin B-selected clones. We
therefore verified by PCR analysis that unspecific integra-
tion of linear vector DNA had not occurred in any of the
hygromycin B-resistant clones (Figure 4B, IV and VII–IX),
providing proof that the cell clones carrying a site-directed
insertion did not carry additional background vector
insertions.
Our findings provide, to our knowledge, the first proof-of-
principle that integration of lentiviral DNA can be facili-
tated by a nonviral recombinase, thereby altering the inte-
gration profile of LV vectors – in this case towards a site-
directed profile using DNA circles as a substrate for gene
insertion. The normal catalytic activities of the lentiviral
integrase were replaced in a drug-selective approach with
the site-directed properties of the yeast Flp recombinase.
As Flp recognition sites are not present in the human
genome, an eGFP fusion gene containing the FRT
sequences was inserted by a novel transposon-based FRT
docking vector prior to IDLV transduction. The site-
directed approach allowing insertion only in the genomic
engineered sites resulted, as expected, in a fairly low inser-
tion rate. As more potent alternatives, LV-hybrids with
integration machineries derived from the phage ΦC31
integrase [18], hyperactive Sleeping Beauty transposases
[19] or the AAV Rep protein [20] will have direct relevance
in human cells, although cut-and-paste transposon sys-
tems would be preferred to mimimize the risk of generat-
ing double-strand DNA breaks as a possible outcome of
recombinase-based insertion of linear substrates. Site-
directed integration technologies based on the recombi-
nation capabilities of tyrosine recombinases as Cre or Flp
have been widely used to direct targeted insertion of non-
viral DNA plasmid substrates into genomic recognition
sites. Flp-mediated plasmid insertion routinely allows
genetic engineering of easy-to-transfect cell lines and has
become pivotal in comparative gene expression studies in
which integrated transgenes of interest may otherwise be
variably influenced by the surrounding DNA. Our data
describe a lentivirus-based technology with possible
implication for Flp-mediated gene insertion in hard-to-
transfect cell lines or potentially in FRT-tagged tissues or
primary cells that are not easily transfected. Recent evi-
dence has supported the fact that episomal lentiviral cir-
cles are highly stable in non-dividing cells and may
provide persistent transgene expression in vivo [8]. For
many applications, the stability of lentiviral circles in non-
dividing cells does not call for genomic integration of the
transgene. Nevertheless, stable viral episomes may repre-
sent permanent targets for recombinase-directed insertion
of lentiviral circles in non-dividing cells.
The obvious difference in efficiency (as measured by the
number of hygromycin B-resistant colonies) between
plasmid- and the LV circle-based Flp integration systems
(Figure 3A versus Figure 3B and 3D) may reflect differ-
ences in the availability of circular substrates in the two
systems (plasmid DNA versus LV circles) or, alternatively,
that plasmid DNA is somehow better suited for Flp-based
insertion. Quantitative PCR analyses comparing the
number of plasmids in transfected cells with the number
of episomal 2-LTR DNA circles in LV-transduced cells
indicated that about 600 times more episomal DNA cir-
cles are available in the plasmid-based system compared
to the LV-based system (1.3 × 104 plasmids per cell com-
pared to 22 2-LTR DNA circles per cell). However, as we
found that 50% of the hygromycin B-resistant clones were
the result of 2-LTR circle insertions, we estimate that the
high number of plasmids available in transfected cells
produced only 52 times more hygromycin B-resistant col-
onies than transduced 2-LTR episomes (2546 versus 48.5
colonies), leading to the assumption that LV-derived 2-
LTR circular DNA is more efficiently integrated than plas-
mid-based substrates. Possible explanations for this find-
ing, including varying substrate concentrations in
different cellular compartments and differences in accessi-
bility caused by structural substrate constraints (relaxed
versus supercoiled substrates), are currently subjects for
further scrutiny. Comparable levels of colony formation
in experiments using IDLVs as a source of Flp recombinase
and/or circular DNA substrates (Figure 3B, C, and 3D)
indicate that both virus-derived Flp and DNA substrates
are limiting factors for efficient Flp-based gene insertion.
By integrating viral circles rather than plasmid DNA, we
obtained Flp-based insertions that are not potentially har-
nessed by bacterial sequences derived from the plasmid
backbone. A recent in vivo study has shown an increase in
heterochromatin-like histone modifications correlating
with lower levels of transgene expression from transfectedPage 8 of 10
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plasmids devoid of bacteria-derived DNA [21]. Together,
our findings provide a novel tool for Flp-based genetic
engineering and pave the way for future applications of
lentiviral DNA circles as potential substrates for more
therapeutic relevant nonviral integration machineries in
somatic gene transfer.
Conclusion
Site-specific integration systems as Cre and Flp are impor-
tant tools in genetic engineering and animal transgenesis
but can in some instances be hampered by the require-
ment for transfection of plasmid DNA. Lentiviral vectors
efficiently transduce both proliferating and quiescent cells
but have a preference for integration into transcriptional
units thereby representing a potential risk of insertional
mutagenesis. A portion of the lentiviral DNA in trans-
duced cells is converted into episomal circlular forms. We
have herein demonstrated for the first time that an exoge-
nous recombinase has access to lentiviral DNA as sub-
strate for DNA insertion with the potential of altering the
integration profile of HIV-1-derived vectors. In the present
setup we combined lentiviral delivery with the site-spe-
cific integration properties of the Flp recombinase in a
drug-selective approach. By packaging the viral vector
with the inactive D64V integrase mutant we were able to
increase the amount of circular substrates 4-fold and at
the same time abolish the viral integration machinery. We
Southern blot and PCR analysis confirm precise insertion of lentiviral derived DNA circles (A) Southern blot anal-ysis of represent tive hygromycin B-resistant clones containing i sert d lentiviral circlesFigure 4
Southern blot and PCR analysis confirm precise insertion of lentiviral derived DNA circles (A) Southern blot anal-
ysis of representative hygromycin B-resistant clones containing inserted lentiviral circles. Genomic DNA was digested with 
XbaI, which cuts within the duplicated FRT sites, generating a ~5400/5630-bp fragment (1-LTR and 2-LTR insertions, respec-
tively) recognized by the indicated hygro probe. Length differences between 1- and 2-LTR insertions could be resolved on a 
shorter exposure of the membrane (not shown). (B) PCR-based characterization of vector insertions in transduced cells. 
Genomic DNA from ten (taken from (3B)) and twelve (taken from (3D)) hygromycin B-resistant clones was used for PCR 
analysis to confirm site-specific insertion into an engineered FRT site (panel I–II and V–VI), integration of circular DNA sub-
strates containing one or two LTRs (panel III and VII), and finally to verify that unspecific insertions of IDLV/FRT-hygro or 
IDLV/PGK-Flp had not occurred (panel IV and VIII–IX). N and P indicate negative (HEK/FGIP1) and positive (pLV/FRT-hygro or 
pLV/PGK-Flp) control clones, respectively.Page 9 of 10
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into engineered FRT acceptor sites in the genome of
human cells by trans-acting Flp recombinase delivered
either by Flp-encoding transfected plasmid DNA or by co-
transduced integrase-defective lentiviral vectors carrying a
Flp expression cassette. Among several advantages of this
approach, genetic cargo inserted as viral DNA circles is not
potentially harnessed by bacterial sequences derived from
the plasmid backbone, the latter which is believed to neg-
atively affect the long-term stability of transgene expres-
sion. Moreover, this hybrid lenti-Flp technology may be
usefull in studies that require Flp-mediated gene insertion
in hard-to-transfect cell lines. Our findings provide evi-
dence that trans-acting integrases are able to gain access to
and insert transduced lentiviral DNA and open up for the
development of new hybrid systems which do not rely on
an engineered genomic target sequence and which are
based on more therapeutically relevant recombinases or
transposases for potential use in gene transfer.
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